Contents
On this page
- Declaration of Pubrica’s conflict of interest
- Scope of outsourced medical writing
- Primacy of the disclosure obligation
- Circumstances in which outsourcing is beneficial
- Circumstances in which outsourcing is not beneficial
- Distinction between writing support and ghostwriting
- Elements of a compliant acknowledgement
- Criteria for assessing a provider
- Timelines and the retention of interpretive responsibility
- Limitations of the available evidence
- Key points
- Application to your study
- Frequently asked questions
Academy · Research Writing · Outsourcing medical writing
Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements
Pubrica provides medical writing services, and readers should consider this article with that interest in mind. The defensible position is narrow: professional writing support assists with reporting, capacity and compliance, but it cannot remedy a study that is unable to answer its research question. In all cases, such support must be acknowledged, and survey evidence indicates that the remaining resistance to disclosure arises from academic authors rather than from sponsors or writers.
Articles on this topic are frequently written for promotional purposes. Pubrica has a commercial interest in authors outsourcing, which is a reason to specify the cases in which they should not. The decision depends on the nature of the problem. Where the study is sound and reporting is the constraint, for example capacity, guideline compliance or an unfamiliar document type, outsourcing is a reasonable purchase. Where the question, the design or the analysis is the problem, it is not, and no amount of writing will alter that. The disclosure obligation applies in either case.
Learning objectives
- The scope of professional medical writing support, and the boundary it cannot cross
- The disclosure obligation in practice: acknowledgement reported by 96–100% of industry, agency and CRO respondents
- The sources of ethical pressure: 38% of agencies and 50% of freelancers had seen an unethical request in a year
- Circumstances in which outsourcing does not address the underlying problem
- The eight criteria for assessing a provider, and the governance indicators to enquire about
- Writing an acknowledgement that satisfies ICMJE and GPP requirements without overstating the writer’s role
Common misconceptions
- “Using a writer is something to keep quiet about.” It is a declarable contribution. Wager and colleagues found acknowledgement reported by 96% of industry, 99% of agency and 100% of contract research organisation respondents, whereas 11% to 13% knew of academic authors who initially refused to acknowledge writing support. The reticence therefore lies with authors.
- “A writer can be listed as an author if they wrote most of it.” Authorship requires all four ICMJE criteria, including a substantial contribution to the research itself. Writing alone does not qualify, irrespective of how much of the text a writer produced.
- “Outsourcing improves my chance of acceptance.” No peer-reviewed study has established such an effect. Outsourcing may remove avoidable reporting objections, which has value; no reputable provider can guarantee acceptance.
- “Ghostwriting is a pharmaceutical industry problem.” The survey data indicate the opposite with regard to disclosure resistance, and 50% of freelancers reported having received an unethical request, a higher proportion than among agencies.
- “Cost is the main thing to compare between providers.” Nagdev and Agrawal list cost-effectiveness as one of eight criteria, alongside quality, resources, communication and the contract. Price is the most easily compared criterion and the least informative.
Declaration of Pubrica’s conflict of interest
Pubrica provides the service that this page discusses. It therefore has an interest in readers concluding that outsourcing is advisable, and what follows should be discounted accordingly. This conflict has been addressed by organising the page around the cases in which outsourcing is the wrong purchase, by stating explicitly where evidence does not exist, and by not citing any commercial source in support of a claim about effectiveness.
One claim in particular should be identified as unsupported. The common assertion that professional writing support raises acceptance rates has, to Pubrica’s knowledge, no peer-reviewed evidence behind it, and the sources that make it are almost entirely vendors. It is not repeated here. The published evidence supports a different and narrower conclusion: writing support is a widespread, disclosed and governed practice in industry-sponsored publication, and the governance arrangements surrounding it vary in ways that warrant enquiry before any contract is agreed.
Scope of outsourced medical writing
The term covers several distinct services with different risk profiles, and conflating them is the principal source of confusion about what is legitimate.
Regulatory and clinical documentation, comprising clinical study reports, protocols, investigator brochures and submission modules, is the largest category by volume and the most procedural. The source material is defined, the format is prescribed, and the writer’s task is accurate assembly. Pubrica’s regulatory writing page covers this work.
Publication writing means drafting or redrafting a manuscript, abstract or poster from data and analyses supplied by the research team. The disclosure obligation applies most strongly here, because the output carries the names of academic authors.
Editing is a separate service, offered at different levels: structural work on a draft written by the authors (developmental editing), sentence-level work (copy-editing and proofreading), and scientific editing where the reviewer has subject expertise. Confusion between these levels is the most common reason authors overpay, for example paying for proofreading when the structure is flawed, or for a full rewrite when the draft required only brief reordering.
Methodological and statistical work, comprising the design and conduct of analyses, the construction of search strategies and data extraction, is not writing and should not be purchased as though it were. It belongs with biostatistics or systematic review support, and the person who undertakes it may qualify for authorship under the research-contribution criterion, which a writer does not meet 1.
Primacy of the disclosure obligation
The central requirement of this page is that writing support must be acknowledged. The ICMJE Recommendations set four authorship criteria, all of which each listed author must meet: substantial contribution to conception or design or to data acquisition, analysis or interpretation; drafting or critical revision; approval of the final version; and accountability for the work 1. A professional writer who drafted the manuscript but had no part in the research does not meet the first criterion and is therefore not an author. The ICMJE position is that such contributors are named in the acknowledgements with their contribution described, and that the funding source for their involvement is disclosed 1. Good Publication Practice states the same requirement for industry-sponsored work, in greater operational detail.
Survey evidence indicates how well established this practice now is. Wager and colleagues’ Global Publication Survey in BMJ Open collected responses from 469 publication professionals in 23 countries 11. Acknowledgement of medical writing support was reported by 96% of industry respondents, 99% of agency respondents and 100% of those working at contract research organisations 11. The same survey found that 93% of respondents routinely referred to the ICMJE requirements and 91% to Good Publication Practice, compared with only 34% who referred to COPE guidance.
A more notable finding concerns the source of resistance. Between 11% and 13% of respondents knew of academic authors who had initially refused to be acknowledged for their own contribution. This contradicts the common perception among authors: the discomfort about disclosure lies on the academic side rather than with sponsors or agencies 11. Our pages on Good Publication Practice and the ICMJE recommendations set out the requirements in full.
Responses from 469 publication professionals in 23 countries. Source: Wager E, Woolley K, Adshead V, et al. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey. BMJ Open.
Circumstances in which outsourcing is beneficial
Such cases exist, and they share a common feature: the science is settled and the document is the constraint.
- Capacity against a fixed deadline. A clinical study report or a submission module has a fixed deadline and a defined format. This is the strongest case for outsourcing, because the work is largely assembly and the cost of delay is concrete.
- An unfamiliar document type. A first systematic review, a first regulatory submission or a first grant application. The value lies in knowledge of the conventions, not in a better understanding of the data than the authors possess.
- Reporting-guideline compliance. Mapping a draft against CONSORT 2010, PRISMA 2020 or STROBE and listing the unmet items is a mechanical and laborious task that authors frequently omit 5,15,18. Von Elm and colleagues’ STROBE statement in the BMJ contains 22 items, 18 of which are common to cohort, case-control and cross-sectional designs; working through them is a task that benefits from a specialist 11,18.
- Structural diagnosis of a draft by an independent reader. Whether the introduction ends in an answerable question, whether the results report the primary outcome in the order stated in the methods, and whether any material appears for the first time in the discussion. Authors are poor judges of these matters in their own manuscripts.
- Programme-level consistency. Where a trial generates several outputs across journals and congresses, consistency of numbers and claims across documents is a genuine administrative problem.
Circumstances in which outsourcing is not beneficial
This list is more important than the preceding one, because these are the cases in which authors incur cost without benefit.
- The study cannot answer its question. A design that was never capable of supporting the claim does not become capable through better prose. This is the most common unproductive purchase that Pubrica encounters.
- The sample is underpowered, or the control group was never recruited. Settled before drafting; unreachable afterwards.
- The primary outcome was never pre-specified. A writer can label the analysis as exploratory, which is the appropriate course, but cannot make it pre-planned.
- The analysis is wrong. This is a problem for a statistician, and purchasing writing instead produces a well-written manuscript that attracts the same objection.
- The author is the only person who understands the dataset. Where the data are complex, idiosyncratic or still being interpreted, the cost of briefing a writer exceeds the cost of writing, and the result is usually inferior to what the author would have written.
- The manuscript has been rejected on scope. That is a journal selection problem. Rewriting does not resolve it; a different choice of journal does.
- The author needs to acquire the skill. For early-career researchers, the first few papers are the means by which the skill is acquired. Outsourcing them secures a publication but forgoes the capability, a trade-off that should be made deliberately rather than by default.
A related case should also be noted: a second opinion on whether the paper merits submission at all. This is a legitimate service, but it constitutes advice rather than writing, and it should be priced and delivered as advice.
Distinction between writing support and ghostwriting
Legitimate writing support means that a writer prepares or revises text under the direction of named authors who control the content, approve the final version and are accountable for it, and whose involvement is disclosed. Ghostwriting means that the named authors did not substantively direct or control the content, that the writer’s involvement was concealed, or that the sponsor shaped conclusions the authors did not independently reach. The distinction does not depend on the number of words the writer produced. It depends on who determined what the paper claims, and on whether the arrangement is transparent.
The Global Publication Survey quantified how often this boundary is tested. Among respondents, 38% of agencies had been aware of an unethical request in the previous twelve months (10% once and 28% more than once), and 50% of freelancers reported such requests 11. More encouragingly, 92% of those requests were withdrawn or amended once the guidelines were explained, and 3% were ultimately complied with.
These findings have several implications. Requests of this kind are not rare. Freelancers, who have the least structural protection, report them more often than agencies do 11. In most cases an explanation of the guideline resolves the matter, which means that a provider familiar with the guidelines is a practical safeguard rather than a formality. A residual few per cent of requests were complied with, which is why asking a provider directly how it handles such a request is a reasonable rather than an offensive question.
Unethical requests and their outcomes
| Measure | Reported | What it suggests |
|---|---|---|
| Agencies aware of an unethical request in the previous 12 months | 38% (10% once, 28% more than once) | Not rare, and usually not isolated |
| Freelancers reporting such requests | 50% | Those with the least structural protection encounter them most often |
| Requests withdrawn or amended once guidelines were explained | 92% | Knowing the guideline is a practical safeguard |
| Requests ultimately complied with | 3% | A residual minority, which is why the question merits asking |
Wager E, Woolley K, Adshead V, et al. The Global Publication Survey, BMJ Open (469 respondents, 23 countries). Respondents self-reported; the survey describes what publication professionals say about their own sector.
Elements of a compliant acknowledgement
Most non-compliant acknowledgements are not attempts to deceive; they are vague because the author was uncertain what to state. Vagueness is nevertheless the problem. An acknowledgement must allow a reader to determine who did what, who funded it, and that the authors retained control.
The same writing support, declared in two ways (a constructed example)
Non-compliant
The authors thank all those who assisted in the preparation of this manuscript. Editorial assistance is gratefully acknowledged.
Nobody is named. A reader cannot determine whether one person proofread the draft or wrote it.
“Editorial assistance” is undefined. It covers everything from a grammar check to a complete first draft.
No funding source for the support. ICMJE expects the source to be disclosed, and its absence is what makes an arrangement appear concealed.
No statement of author control. This is precisely the question that a reader or editor is asking.
No scope. A reader cannot judge whether the authorship line is correct.
Compliant
Medical writing support was provided by A. N. Writer (Pubrica, Chennai, India), who prepared the first draft and incorporated author revisions under the direction of the named authors. This support was funded by [sponsor / grant number]. All authors directed the content, critically revised the manuscript, approved the final version, and are accountable for its accuracy and integrity. The authors retained full control over the content and the decision to submit.
The writer and their affiliation are named, so the contribution is attributable.
The scope is specific (first draft and incorporation of revisions), so a reader can judge whether authorship was correctly assigned.
The funding source for the writing support is disclosed separately from study funding.
Author direction, revision, approval and accountability are all asserted, matching the four ICMJE criteria.
Control over the content and the submission decision is stated, which marks the boundary between support and ghostwriting.
The second version is longer and discloses more, which is its purpose. Every element about which a reader might otherwise be uncertain is supplied: who, what scope, funded by whom, and who made the decisions. It also protects the authors, because an acknowledgement this specific makes it difficult to characterise the arrangement subsequently as concealed, and it is the version that satisfies both the ICMJE criteria and Good Publication Practice.
Criteria for assessing a provider
Nagdev and Agrawal, writing in Medical Writing, propose eight criteria for a pharmaceutical company choosing a medical writing provider: types of services, organisational structure, resources, quality of services, communication, client relationship, contract, and cost-effectiveness 12. The framing is directed at industry, but the criteria apply equally to an academic group purchasing publication support, and a useful feature of the list is that cost appears last.
The governance questions highlighted by the Global Publication Survey should be added to these eight criteria, because the survey found governance to be unevenly distributed across the sector. Formal compliance monitoring was reported by 61% of industry respondents and 60% of those at contract research organisations, but by only 44% of agencies 11. Publication audits were reported by 46% of industry respondents, 47% of CRO respondents and only 20% of agencies. Agencies were therefore the least likely to be formally monitored or audited, which is a reason to ask any provider about its own compliance process, who checks it and how often 11.
Four questions address most of the relevant issues: which guidelines the provider follows and whether it can state the acknowledgement requirement; what compliance monitoring it has and who performs it; how it handles a request it considers unethical; and who owns the data, the drafts and the correspondence under the contract. A provider that answers all four readily is probably suitable. A provider that regards the third question as unusual has revealed something significant.
Eight provider criteria and the corresponding question for each
| Criterion | The question to ask | What a weak answer looks like |
|---|---|---|
| Types of services | Which of these do you do in-house, and which do you subcontract? | An undifferentiated list covering everything |
| Organisational structure | Who will actually write this, and who reviews their work? | No named reviewer, or no structure above the writer |
| Resources | What subject and statistical expertise sits behind the writer? | Subject expertise asserted but never evidenced |
| Quality of services | What is your quality process, and can I see a redacted sample? | Testimonials in place of a process |
| Communication | Who is my point of contact, and what is the escalation route? | A single channel with no named owner |
| Client relationship | How are author review and sign-off handled, with what dates? | An open-ended review step |
| Contract | Who owns the data, the drafts and the correspondence? | Ownership unaddressed, or claimed by the provider |
| Cost-effectiveness | What is included, and what triggers a change in scope? | A single figure with no scope definition |
Criteria from Nagdev KJ, Agrawal AR. Key factors a pharmaceutical company should consider while outsourcing medical writing services. Medical Writing. The questions and the weak-answer column are Pubrica’s interpretation, not findings from that paper.
Timelines and the retention of interpretive responsibility
Where external support is engaged, the timing of the engagement matters more than its size. The Global Publication Survey asked industry respondents about submission targets after study completion: 43% targeted submission within 12 months and 18% within 18 months, while 24% had no target deadline at all 11. Separately, 67% said their company was committed to publishing all human studies.
These figures concern industry publication planning rather than academic practice, and they should not be interpreted as a benchmark for a university group. They illustrate that the organisations that publish most reliably treat the timeline as a planned schedule with fixed dates, and that a quarter of them still do not 11. When a writer is engaged, the dates for data availability, first draft, author review and submission should be fixed at the outset; the most common cause of an unsatisfactory outsourcing experience is an open-ended engagement in which the author review step has no date.
Interpretation is the component least suited to outsourcing. A writer can draft the discussion, but the choice among several plausible readings of the data that the authors are prepared to defend is a judgement that only the authors can make, and under the ICMJE criteria it is a judgement they are required to make 1. Where that work is delegated entirely, the arrangement has moved towards ghostwriting, irrespective of the wording of the acknowledgement.
Limitations of the available evidence
Three gaps in the evidence are stated here because a page promoting this service has every incentive to omit them.
First, there is no evidence that outsourcing improves acceptance. Pubrica searched for such evidence, and the only sources making the claim are commercial. A provider that asserts it has thereby revealed something about itself.
Second, almost all the quantitative evidence presented here derives from a single source: Wager and colleagues’ Global Publication Survey, with 469 respondents across 23 countries, published in BMJ Open in 2014 11. It surveyed publication professionals, and it therefore reports what the sector says about its own practice rather than the results of independent observation 11. It is also a decade old and predates the current revisions of several of the guidelines about which it asked.
Third, there is almost no evidence on academic, non-industry outsourcing, in which a researcher pays for assistance with a manuscript from a grant or personal funds. The governance literature concerns sponsored publication programmes. The disclosure obligation is identical, but the prevalence, the distribution of quality and the outcomes are not documented. Any claim to the contrary is an extrapolation.
Key points
Key points
Outsourcing medical writing is a reasonable purchase when the science is settled and the document is the constraint: limited capacity against a deadline, an unfamiliar document type, reporting-guideline compliance, or structural diagnosis of a draft. It is inappropriate when the design cannot answer the question, the sample is underpowered, the outcome was not pre-specified or the analysis is the problem. The disclosure obligation is not optional: writing support is acknowledged by name, with its scope and funding source, and the authors must retain control of the content. Acknowledgement is reported by 96% to 100% of industry, agency and CRO respondents, and 11% to 13% have encountered academic authors who resisted it; reluctance to disclose therefore warrants scrutiny of that reluctance rather than of the arrangement.
Application to your study
Application to your study
- Define the problem before selecting the service. Determine whether the principal constraint is the design, the analysis, the reporting or capacity. Only the last two are addressed by writing support.
- Where the problem is design or analysis, writing support is not the appropriate remedy. Statistical or methodological input is required instead, and the paper may need to make a more limited claim.
- Apply the four ICMJE criteria to every contributor. A writer who had no part in the research is acknowledged rather than listed as an author, irrespective of the volume of text produced.
- Draft the acknowledgement at the start of the engagement rather than at the end. State the person’s name, affiliation, the scope of the contribution and the funding source.
- Ask the provider which guidelines it follows and to state the acknowledgement requirement. A provider unable to do so is not equipped to protect the authors.
- Ask how the provider handles a request it considers unethical. Most such requests are withdrawn once the guidelines are explained, which depends on the provider knowing them.
- Ask what compliance monitoring the provider has and who performs it. Monitoring was reported by only 44% of agencies against 61% of industry respondents, so the question discriminates meaningfully between providers.
- Agree the dates before work begins. These include data availability, first draft, author review and submission. Open-ended author review is the most common point of failure.
- Retain responsibility for interpretation. The interpretation of the data that the authors are prepared to defend cannot be delegated, and the ICMJE criteria require that it is not.
- Early-career researchers should make the decision deliberately. Outsourcing a first paper secures a publication but forgoes the development of the skill; this may be an appropriate trade-off, but it should be made consciously.
Frequently asked questions
Yes. Under the ICMJE Recommendations, contributors who do not meet all four authorship criteria are named in the acknowledgements with their contribution described, and the funding source for that contribution is disclosed. Professional writing support falls clearly within that category, and Good Publication Practice states the same requirement for industry-sponsored work. The practice is well established: Wager and colleagues’ Global Publication Survey in BMJ Open, covering 469 publication professionals in 23 countries, found acknowledgement reported by 96% of industry respondents, 99% of agency respondents and 100% of those at contract research organisations. Notably, 11% to 13% knew of academic authors who had initially refused to be acknowledged, which indicates that hesitation tends to originate with authors rather than sponsors.
Only if they meet all four ICMJE criteria, which writing alone does not satisfy. The first criterion requires a substantial contribution to conception or design, or to data acquisition, analysis or interpretation, that is, a contribution to the research rather than to the text. A writer who drafted the whole manuscript from analyses supplied by the team does not qualify and is acknowledged instead. The converse case should also be checked: a statistician who designed and conducted the analysis, interpreted it, revised the manuscript and approved the final version often does qualify, yet is frequently and incorrectly listed only in the acknowledgements.
When the problem lies in the study rather than the document. A design that cannot answer the question, an underpowered sample, a control group that was never recruited, an outcome that was never pre-specified, or an analysis that is incorrect cannot be remedied by better prose, and expenditure on writing produces a well-written manuscript that attracts the same objections. Two further cases apply: where the author is the only person who understands the dataset, the cost of briefing usually exceeds the cost of writing and the output is inferior; and for early-career researchers, outsourcing a first paper secures the publication at the cost of acquiring the skill. Pubrica provides this service and nonetheless regards these cases as genuine.
The distinction lies in who controls the content and whether the arrangement is transparent. Legitimate support means that a writer prepares or revises text under the direction of named authors who decide what the paper claims, approve the final version, are accountable for it, and disclose the writer’s involvement. Ghostwriting means that the named authors did not substantively direct the content, that the involvement was concealed, or that a sponsor shaped conclusions the authors did not independently reach. The number of words the writer produced is not the criterion. In the Global Publication Survey, 38% of agencies and 50% of freelancers had encountered an unethical request within twelve months; 92% of those requests were withdrawn or amended once the guidelines were explained, and 3% were ultimately complied with.
There is no peer-reviewed evidence that it does, and Pubrica does not claim otherwise. The sources asserting an acceptance benefit are commercial. Writing support can plausibly remove avoidable reporting objections (unmet reporting-guideline items, an abstract without quantitative results, interpretation misplaced in the results section, or a methods section that relies on the reader’s trust) and make a sound study readily intelligible to an editor reading quickly. This is of value in its own right. A provider that offers an improvement in acceptance, or anything resembling a guarantee, thereby reveals something significant about itself.
Nagdev and Agrawal, in Medical Writing, set out eight criteria: types of services, organisational structure, resources, quality of services, communication, client relationship, contract and cost-effectiveness, with cost appropriately placed last. The governance questions highlighted by the Global Publication Survey should be added, because practice varies: formal compliance monitoring was reported by 61% of industry and 60% of CRO respondents but by only 44% of agencies, and publication audits by 46%, 47% and 20% respectively. Four questions cover most of the relevant issues: which guidelines the provider follows, what compliance monitoring it has and who performs it, how it handles a request it considers unethical, and who owns the data, drafts and correspondence under the contract.
The acknowledgement should name the person and their affiliation, state the scope of the contribution, disclose who funded the support and assert author control. For example: medical writing support was provided by a named writer at a named organisation, who prepared the first draft and incorporated author revisions under the direction of the named authors; that support was funded by a named sponsor or grant; and all authors directed the content, critically revised the manuscript, approved the final version and are accountable for it. “Editorial assistance is gratefully acknowledged” is inadequate because it names nobody, defines no scope, discloses no funding and makes no statement about who controlled the content, which is precisely what a reader seeks to establish.
Early enough that the data are stable and late enough that the analysis is settled, and with fixed dates from the outset. The Global Publication Survey found that 43% of industry respondents targeted submission within 12 months of study completion and 18% within 18 months, while 24% had no target deadline at all; 67% said their organisation was committed to publishing all human studies. These figures describe industry publication planning rather than academic practice and are not a benchmark for a university group. The transferable lesson is that the organisations that publish most reliably treat the timeline as a planned schedule with dates, and that the most common cause of an unsatisfactory engagement is an author review step with no date attached.
Very little, and this is the largest gap on the page. Nearly all the quantitative evidence available derives from Wager and colleagues’ Global Publication Survey of 469 publication professionals across 23 countries, published in BMJ Open in 2014, which surveyed people working in industry-sponsored publication and reports what the sector says about its own practice. Pubrica found no evidence documenting prevalence, quality or outcomes for individual researchers paying for assistance with a manuscript from a grant or personal funds. The disclosure obligation is identical in that case, but there is no evidence base on how well it operates, and any account presenting one is an extrapolation.
References
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. 2026. read 9 October 2026. icmje.org
- US Department of Health and Human Services, Food and Drug Administration (CDER, CBER, CDRH). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. read 9 October 2026. hhs.gov
- Bloothooft M, Pennings HJM, van der Heyden MAG. The Utrecht University Honours Program review project: example based scientific publishing training aimed at bachelor medical students. BMC Medical Education. 2024;24(1):1-12. doi:10.1186/s12909-024-05098-7 read 9 October 2026. doi.org/10.1186/s12909-024-05098-7
- Borowiec BG. Ten simple rules for scientists engaging in science communication. PLOS Computational Biology. 2023;19(7):e1011251. doi:10.1371/journal.pcbi.1011251 read 9 October 2026. doi.org/10.1371/journal.pcbi.1011251
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:n71. doi:10.1136/bmj.n71 read 9 October 2026. doi.org/10.1136/bmj.n71
- Jawaid SA, Jawaid M. Common reasons for not accepting manuscripts for further processing after editor's triage and initial screening. Pakistan Journal of Medical Sciences. 2019;35(1):1-3. doi:10.12669/pjms.35.1.28 read 9 October 2026. doi.org/10.12669/pjms.35.1.28
- Pasarica M, Bailey M, Cendan JC. Increasing students' publication productivity: could launching a university scientific journal be a catalyst? Cureus. 2019;11(1):e3953. doi:10.7759/cureus.3953 read 9 October 2026. doi.org/10.7759/cureus.3953
- Sterne JAC, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. read 9 October 2026. frontiersin.org
- Fujita MSL, Agustin-Lacruz MdC, Terra AL. Journals' guidelines about title, abstract and keywords: an overview of Information Science and Communication Science areas. European Science Editing. 2018;44(4):76-79. read 9 October 2026. europeanscienceediting.org.uk
- Bannas P, Reeder SB. How to write an original radiological research manuscript. European Radiology. 2017;27(11):4455-4460. doi:10.1007/s00330-017-4879-8 read 9 October 2026. doi.org/10.1007/s00330-017-4879-8
- Wager E, Woolley K, Adshead V, Cairns A, Fullam J, Gonzalez J, Grant T, Tortell S. Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey. BMJ Open. 2014;4(4):e004780. doi:10.1136/bmjopen-2013-004780 read 9 October 2026. doi.org/10.1136/bmjopen-2013-004780
- Nagdev KJ, Agrawal AR. Key factors a pharmaceutical company should consider while outsourcing medical writing services. Medical Writing. 2014;23(3):223-227. read 9 October 2026. emwa.org
- von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J. The STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement: guidelines for reporting observational studies. International Journal of Surgery. 2014. doi:10.1016/j.ijsu.2014.07.013 read 9 October 2026. doi.org/10.1016/j.ijsu.2014.07.013
- Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology. 2011;64(4):383-394. read 9 October 2026. link.springer.com
- Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11(1). doi:10.1186/1745-6215-11-32 read 9 October 2026. doi.org/10.1186/1745-6215-11-32
- Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ. 2008;337:a288. read 9 October 2026. link.springer.com
- Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. read 9 October 2026. link.springer.com
- von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. doi:10.1136/bmj.39335.541782.AD read 9 October 2026. doi.org/10.1136/bmj.39335.541782.AD
- Kliewer MA. Writing it up: a step-by-step guide to publication for beginning investigators. American Journal of Roentgenology. 2005;185:591-596. read 9 October 2026. tech.snmjournals.org
- Sollaci LB, Pereira MG. The Introduction, Methods, Results, and Discussion (IMRAD) structure: a fifty-year survey. Journal of the Medical Library Association. 2004;92(3):364-371. read 9 October 2026. genreacrossborders.uwaterloo.ca
- International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. Annals of Internal Medicine. 1997;126(1):36-47. read 9 October 2026. stat.cmu.edu
- Vickery B. The Royal Society Scientific Conference of 1948. Journal of Documentation. 1992;54(3):281-283. read 9 October 2026. stat.cmu.edu
- Atkinson D. The evolution of medical research writing from 1735 to 1985: the case of the Edinburgh Medical Journal. Applied Linguistics. 1992;13(4):337-374. read 9 October 2026. stat.cmu.edu
- Huth EJ. Structured abstracts for papers reporting clinical trials. Annals of Internal Medicine. 1987;106(4):626-627. read 9 October 2026. stat.cmu.edu
- Meadows AJ. The scientific paper as an archaeological artifact. Journal of Information Science. 1985;11(1):27-30. read 9 October 2026. stat.cmu.edu
- Bazerman C. Modern evolution of the experimental report in physics: spectroscopic articles in Physical Review, 1893-1980. Social Studies of Science. 1984;14:163-196. read 9 October 2026. stat.cmu.edu
- Radiology (Radiological Society of North America). Radiology scientific style guide and author instructions: scientific editing. Radiology. read 9 October 2026. pubs.rsna.org
- Fernandez E, Garcia AM, Seres E, Bosch F. Students' satisfaction and perceived impact on knowledge, attitudes and skills after a 2-day course in scientific writing: a prospective longitudinal study in Spain. BMJ Open. 8(1):e018657. read 9 October 2026. bmjopen.bmj.com
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements. Pubrica. https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/
Pubrica Academy. “Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements.” Pubrica, 9 Oct. 2026, pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/.
Pubrica Academy (2026) Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements. Pubrica. Available at: https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/ (Accessed: 15 October 2026).
Pubrica Academy. “Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements.” Pubrica. October 9, 2026. https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/
Pubrica Academy, ‘Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/> accessed 15 October 2026.
Pubrica Academy. Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/
Pubrica Academy, “Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/
@misc{reasons_to_outsource_your_projects_in__2026,
author = {{Pubrica Academy}},
title = {Outsourcing Medical Writing: Appropriate Use, Limitations and Disclosure Requirements},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/medical-writing/reasons-to-outsource-your-projects-in-medical-writing/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Decision and engagement checklist you can copy
Part A determines whether to outsource at all and should be completed before any provider, including Pubrica, is contacted. Part B covers the matters to be agreed before work starts. Part C is the acknowledgement, which is easier to draft at the outset than at submission.
OUTSOURCING MEDICAL WRITING: DECISION AND ENGAGEMENT
==== PART A: SHOULD I OUTSOURCE THIS AT ALL? ====
My actual bottleneck is (tick one honestly):
[ ] The study design cannot answer my question ....... DO NOT outsource writing
[ ] The sample is underpowered ....................... DO NOT outsource writing
[ ] The primary outcome was never pre-specified ...... DO NOT outsource writing
[ ] The analysis is wrong or incomplete .............. Buy statistics, not writing
[ ] Rejected on scope ................................ Change journal, not prose
[ ] I am the only person who understands the data .... Briefing cost likely exceeds benefit
[ ] I need to learn to do this myself ................ Deliberate trade-off - decide consciously
[ ] Capacity against a fixed deadline ................ Reasonable case
[ ] A document type I have not written before ........ Reasonable case
[ ] Reporting-guideline compliance ................... Reasonable case
[ ] Structural diagnosis on a draft I am too close to Reasonable case
[ ] Consistency across several outputs from one trial Reasonable case
==== PART B: BEFORE WORK STARTS ====
PROVIDER QUESTIONS (ask all four; note the answers)
1. Which guidelines do you work to, and what is the acknowledgement
requirement? ____________________________________________
2. What compliance monitoring do you have, and who performs it?
________________________________________________________
3. How do you handle a request you consider unethical?
________________________________________________________
4. Who owns the data, the drafts and the correspondence?
________________________________________________________
EIGHT CRITERIA (score each 1-5)
Types of services ____ Organisational structure ____
Resources ____ Quality of services ____
Communication ____ Client relationship ____
Contract ____ Cost-effectiveness ____
SCOPE AND DATES
Deliverable: ______________________ Target journal: ______________
Reporting guideline to be applied: ______________________
Data available to writer by ........... ____ / ____ / ____
First draft to authors by ............. ____ / ____ / ____
Author review returned by ............. ____ / ____ / ____
Final version approved by ............. ____ / ____ / ____
Submission by ......................... ____ / ____ / ____
[ ] Author review step has a DATE, not "when convenient"
[ ] Change-of-scope trigger defined in writing
AUTHORSHIP (apply all four ICMJE criteria to EVERY name)
Name ______________ (1) research contribution? ___ (2) drafting/revision? ___
(3) final approval? ___ (4) accountability? ___
Name ______________ (1) ___ (2) ___ (3) ___ (4) ___
[ ] Anyone failing any criterion moves to acknowledgements
[ ] The writer is NOT listed as an author
[ ] Statistical/methodological contributors assessed on criterion (1) too
==== PART C: ACKNOWLEDGEMENT (draft now, not at submission) ====
"Medical writing support was provided by [name, qualification] of
[organisation, city, country], who [scope: e.g. prepared the first draft
and incorporated author revisions] under the direction of the named
authors. This support was funded by [sponsor / grant number]. All authors
directed the content, critically revised the manuscript, approved the
final version, and are accountable for its accuracy and integrity. The
authors retained full control over the content and the decision to submit."
[ ] Writer named, with affiliation
[ ] Scope stated specifically
[ ] Funding source for the writing support disclosed
[ ] Author direction, approval and accountability asserted
[ ] Control over content and submission decision stated Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica writes and edits manuscripts, regulatory documents and submission packages, and acknowledgement of its writing role is a condition of every project. Before quoting, Pubrica indicates whether the problem appears to lie in the design or the analysis rather than the document, because writing work cannot resolve a study problem. Where a project is accepted, the acknowledgement wording is agreed at the outset, the authors retain control of the content, and the dates are fixed in the agreed scope.